Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort

Background: Opportunistic infections remain a significant cause of morbidity and mortality after kidney transplantation. This retrospective cohort study aimed to assess the incidence and predictors of post-transplant DNA virus infections (CMV, EBV, BKV and JCV infections) in kidney transplant recipi...

Full description

Bibliographic Details
Main Authors: Kairi Pullerits, Shona Garland, Sharmilee Rengarajan, Malcolm Guiver, Rajkumar Chinnadurai, Rachel J. Middleton, Chukwuma A. Chukwu, Philip A. Kalra
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/14/11/2406
_version_ 1797466235828436992
author Kairi Pullerits
Shona Garland
Sharmilee Rengarajan
Malcolm Guiver
Rajkumar Chinnadurai
Rachel J. Middleton
Chukwuma A. Chukwu
Philip A. Kalra
author_facet Kairi Pullerits
Shona Garland
Sharmilee Rengarajan
Malcolm Guiver
Rajkumar Chinnadurai
Rachel J. Middleton
Chukwuma A. Chukwu
Philip A. Kalra
author_sort Kairi Pullerits
collection DOAJ
description Background: Opportunistic infections remain a significant cause of morbidity and mortality after kidney transplantation. This retrospective cohort study aimed to assess the incidence and predictors of post-transplant DNA virus infections (CMV, EBV, BKV and JCV infections) in kidney transplant recipients (KTR) at a single tertiary centre and evaluate their impact on graft outcomes. Methods: KTR transplanted between 2000 and 2021 were evaluated. Multivariate logistic regression analysis and Cox proportional hazard analyses were used to identify factors associated with DNA virus infections and their impact on allograft outcomes respectively. A sub-analysis of individual viral infections was also conducted to describe the pattern, timing, interventions, and outcomes of individual infections. Results: Data from 962 recipients were evaluated (Mean age 47.3 ± 15 years, 62% male, 81% white). 30% of recipients (288/962) had infection(s) by one or more of the DNA viruses. Individually, CMV, EBV, BKV and JCV viruses were diagnosed in 13.8%. 11.3%, 8.9% and 4.4% of recipients respectively. Factors associated with increased risk of post-transplant DNA virus infection included recipient female gender, higher number of HLA mismatch, lower baseline estimated glomerular filtration rate (eGFR), CMV seropositive donor, maintenance with cyclosporin (rather than tacrolimus) and higher number of maintenance immunosuppressive medications. The slope of eGFR decline was steeper in recipients with a history of DNA virus infection irrespective of the virus type. Further, GFR declined faster with an increasing number of different viral infections. Death-censored graft loss adjusted for age, gender, total HLA mismatch, baseline eGFR and acute rejection was significantly higher in recipients with a history of DNA virus infection than those without infection (adjusted hazard ratio (aHR, 1.74, 95% CI, 1.08–2.80)). In contrast, dialysis-free survival did not differ between the two groups of recipients (aHR, 1.13, 95% CI, 0.88–1.47). Conclusion: Post-transplant DNA viral infection is associated with a higher risk of allograft loss. Careful management of immunosuppression and close surveillance of at-risk recipients may improve graft outcomes.
first_indexed 2024-03-09T18:33:57Z
format Article
id doaj.art-29704442b7e049b29e207eccf8e3a3f6
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-09T18:33:57Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-29704442b7e049b29e207eccf8e3a3f62023-11-24T07:16:41ZengMDPI AGViruses1999-49152022-10-011411240610.3390/v14112406Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre CohortKairi Pullerits0Shona Garland1Sharmilee Rengarajan2Malcolm Guiver3Rajkumar Chinnadurai4Rachel J. Middleton5Chukwuma A. Chukwu6Philip A. Kalra7Department of Undergraduate Medicine, University of Manchester, Oxford Road, Manchester M13 9PL, UKDepartment of Undergraduate Medicine, University of Manchester, Oxford Road, Manchester M13 9PL, UKDepartment of Nephrology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, UKDepartment of Virology Manchester, University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UKDepartment of Nephrology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, UKDepartment of Nephrology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, UKDepartment of Nephrology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, UKDepartment of Nephrology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, UKBackground: Opportunistic infections remain a significant cause of morbidity and mortality after kidney transplantation. This retrospective cohort study aimed to assess the incidence and predictors of post-transplant DNA virus infections (CMV, EBV, BKV and JCV infections) in kidney transplant recipients (KTR) at a single tertiary centre and evaluate their impact on graft outcomes. Methods: KTR transplanted between 2000 and 2021 were evaluated. Multivariate logistic regression analysis and Cox proportional hazard analyses were used to identify factors associated with DNA virus infections and their impact on allograft outcomes respectively. A sub-analysis of individual viral infections was also conducted to describe the pattern, timing, interventions, and outcomes of individual infections. Results: Data from 962 recipients were evaluated (Mean age 47.3 ± 15 years, 62% male, 81% white). 30% of recipients (288/962) had infection(s) by one or more of the DNA viruses. Individually, CMV, EBV, BKV and JCV viruses were diagnosed in 13.8%. 11.3%, 8.9% and 4.4% of recipients respectively. Factors associated with increased risk of post-transplant DNA virus infection included recipient female gender, higher number of HLA mismatch, lower baseline estimated glomerular filtration rate (eGFR), CMV seropositive donor, maintenance with cyclosporin (rather than tacrolimus) and higher number of maintenance immunosuppressive medications. The slope of eGFR decline was steeper in recipients with a history of DNA virus infection irrespective of the virus type. Further, GFR declined faster with an increasing number of different viral infections. Death-censored graft loss adjusted for age, gender, total HLA mismatch, baseline eGFR and acute rejection was significantly higher in recipients with a history of DNA virus infection than those without infection (adjusted hazard ratio (aHR, 1.74, 95% CI, 1.08–2.80)). In contrast, dialysis-free survival did not differ between the two groups of recipients (aHR, 1.13, 95% CI, 0.88–1.47). Conclusion: Post-transplant DNA viral infection is associated with a higher risk of allograft loss. Careful management of immunosuppression and close surveillance of at-risk recipients may improve graft outcomes.https://www.mdpi.com/1999-4915/14/11/2406kidney transplantationCMV viremiaEBV viremiaBKV viremiaJCV viremia
spellingShingle Kairi Pullerits
Shona Garland
Sharmilee Rengarajan
Malcolm Guiver
Rajkumar Chinnadurai
Rachel J. Middleton
Chukwuma A. Chukwu
Philip A. Kalra
Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort
Viruses
kidney transplantation
CMV viremia
EBV viremia
BKV viremia
JCV viremia
title Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort
title_full Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort
title_fullStr Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort
title_full_unstemmed Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort
title_short Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort
title_sort kidney transplant associated viral infection rates and outcomes in a single centre cohort
topic kidney transplantation
CMV viremia
EBV viremia
BKV viremia
JCV viremia
url https://www.mdpi.com/1999-4915/14/11/2406
work_keys_str_mv AT kairipullerits kidneytransplantassociatedviralinfectionratesandoutcomesinasinglecentrecohort
AT shonagarland kidneytransplantassociatedviralinfectionratesandoutcomesinasinglecentrecohort
AT sharmileerengarajan kidneytransplantassociatedviralinfectionratesandoutcomesinasinglecentrecohort
AT malcolmguiver kidneytransplantassociatedviralinfectionratesandoutcomesinasinglecentrecohort
AT rajkumarchinnadurai kidneytransplantassociatedviralinfectionratesandoutcomesinasinglecentrecohort
AT racheljmiddleton kidneytransplantassociatedviralinfectionratesandoutcomesinasinglecentrecohort
AT chukwumaachukwu kidneytransplantassociatedviralinfectionratesandoutcomesinasinglecentrecohort
AT philipakalra kidneytransplantassociatedviralinfectionratesandoutcomesinasinglecentrecohort